Excellence in Research and Innovation for Humanity

ICBEP 2017 : 19th International Conference on Biomedical Engineering and Pharmacology

Durban, South Africa
January 12 - 13, 2017

Conference Information

ICBEP Home Aims and Objectives Important Dates Call for Papers Committee Conference Program Conference Proceedings Conference Abstracts

Paper Submission

Paper Submission Paper Submission GUIDE

Conference Registration

Author RegistrationListener Registration Payment Registration Fees Sponsorship and Exhibition Volunteer Author Information Presentation Upload Conference Photos

Conference Publicity

Conference Flyer EventsKeynotes

Conference Venue

Holiday Inn Express Durban Umhlanga
2 Ncondo Place, Cnr Ncondo Place & Ntusi Road,
off Umhlanga Rocks Drive
Umhlanga, Durban, 4320, South Africa
Conference Code: 17ZA01ICBEP

Conference Aims and Objectives

The ICBEP 2017: 19th International Conference on Biomedical Engineering and Pharmacology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Biomedical Engineering and Pharmacology. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Biomedical Engineering and Pharmacology.

Call for Contributions

All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Biomedical Engineering and Pharmacology are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index , and submitted to be indexed in the Google Scholar, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk.

Special Journal Issues

ICBEP 2017 has teamed up with the Special Journal Issue on Biomedical Engineering and Pharmacology. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Important Dates

Abstracts/Full-Text Paper Submission Deadline   November 30, 2016
Notification of Acceptance/Rejection   December 5, 2016
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   December 10, 2016
Conference Dates   January 12 - 13, 2017

Important Notes

Please ensure your submission meets WASET's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission GUIDE before submitting your paper.

Selected Conference Papers

1) Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of Rifampicin
Tasnuva Tamanna, Aimin Yu
2) Preparation, Characterisation, and Measurement of the in vitro Cytotoxicity of Mesoporous Silica Nanoparticles Loaded with Cytotoxic Pt(II) Oxadiazoline Complexes
G. Wagner, R. Herrmann
3) Formulation and Evaluation of Niosomes Containing an Antihypertensive Drug
Sunil Kamboj, Suman Bala, Vipin Saini
4) Identification of the Antimicrobial Effect of Liquorice Extracts on Gram-Positive Bacteria: Determination of Minimum Inhibitory Concentration and Mechanism of Action Using a luxABCDE Reporter Strain
Madiha El Awamie, Catherine Rees
5) Quantitative Structure Activity Relationship and Insilco Docking of Substituted 1,3,4-Oxadiazole Derivatives as Potential Glucosamine-6-Phosphate Synthase Inhibitors
Suman Bala, Sunil Kamboj, Vipin Saini
6) Pefloxacin as a Surrogate Marker for Ciprofloxacin Resistance in Salmonella: Study from North India
Varsha Gupta, Priya Datta, Gursimran Mohi, Jagdish Chander
7) Identification of Active Phytocomponents in the Ethyl Acetate Extract of Glycosmis pentaphylla Retz. DC by Using GC-MS
M. Sivakumar, D. Chamundeeswari
8) Quantitative Assessment of Different Formulations of Antimalarials in Sentinel Sites of India
Taruna Katyal Arora, Geeta Kumari, Hari Shankar, Neelima Mishra
9) Investigation into Black Oxide Coating of 410 Grade Surgical Stainless Steel Using Alkaline Bath Treatment
K. K. Saju, A. R. Reghuraj
10) Toxicological and Histopathological Studies on the Effect of Tartrazine in Male Albino Rats
F. Alaa Ali, S. A. Sherein Abdelgayed, S. Osama. EL-Tawil, M. Adel Bakeer
11) Co-payment Strategies for Chronic Medications: A Qualitative and Comparative Analysis at European Level
Pedro M. Abreu, Bruno R. Mendes
12) Green Synthesis of Nanosilver-Loaded Hydrogel Nanocomposites for Antibacterial Application
D. Berdous, H. Ferfera-Harrar
13) Resveratrol Incorporated Liposomes Prepared from Pegylated Phospholipids and Cholesterol
Mont Kumpugdee-Vollrath, Khaled Abdallah
14) An Open-Label Pilot Study of Efficacy and Safety of 2% Curcuma aeruginosa Roxb. Extract Cream in the Treatment of Mild to Moderate Facial Seborrheic Dermatitis
Kulaya Wimolwat, Panlop Chakravitthamrong, Neti Waranuch
15) Formulation and in vitro Evaluation of Sustained Release Matrix Tablets of Levetiracetam for Better Epileptic Treatment
Nagasamy Venkatesh Dhandapani